Header Logo

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert Opin Investig Drugs. 2019 Jun; 28(6):505-511.

View in: PubMed